AMA opposes CVS-Aetna merger

Barbara L. McAneny
AMA has determined that the proposed merger of CVS Health and Aetna should be blocked due to its likely negative consequences for patients and health insurance markets, according to a press release.
“After very careful consideration over the past months, the AMA has come to the conclusion that this merger would likely substantially lessen competition in many health care markets, to the detriment of patients,” Barbara L. McAneny, MD, president of AMA, said during testimony to California Department of Insurance.
During the analysis of the merger, the (Read more...)

STAAR Surgical Announces Resolution of FDA Warning Letter

MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye announced today that it received a close-out letter from the U.S. Food and Drug Administration (FDA) on June 19, 2018 lifting a Warning Letter dated May 21, 2014. “The lifting of the Warning Letter is the result of a comprehensive remediation program that not only addressed the issues raised by the FDA in the 20